MetaCap

CalciMedica Inc. Company Profile

NASDAQ: CALCHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.26+0.09 (+7.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CalciMedica at a glance

CalciMedica Inc. (NASDAQ: CALC) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in La Jolla, CA. CalciMedica is led by Dr. A. Rachel Leheny Ph.D. and employs about 15 people. The company's shares have traded publicly since 2023.

At a market capitalization of $8.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001534133, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does CalciMedica do?

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Business description based on the company's public filings.

Company information

Legal name
CalciMedica Inc.
Ticker
NASDAQ: CALC
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. A. Rachel Leheny Ph.D.
Employees
15
Headquarters
505 Coast Boulevard South, La Jolla, CA, United States
Phone
858 952 5500
IPO year
2023
SEC CIK
0001534133
Latest annual report
10-K/A · Apr 30, 2026

Companies similar to CalciMedica

CALC peer companies
CompanyPrice% ChgMarket capCompare
OPTHOptimi Health Corp.1.51-13.71%$8.65Mvs CALC
BIVIBioVie Inc. Class A0.80-12.07%$8.58Mvs CALC
LEXXLexaria Bioscience Corp.4.03-10.24%$8.49Mvs CALC
HINDVyome Holdings Inc.1.20-17.24%$8.42Mvs CALC
GDTCCytoMed Therapeutics Limited0.755-2.33%$9.01Mvs CALC
QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares1.29-9.15%$8.29Mvs CALC
MBRXMoleculin Biotech Inc.7.74-2.40%$8.22Mvs CALC
PTNPalatin Technologies Inc.4.58-7.10%$8.16Mvs CALC

Related